In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.
Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results